Tang Capital Management »

Athira Pharma shares owned by Tang Capital Management

Quarter-by-quarter ownership of Athira Pharma shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $248k 60k 4.14

More positions owned by Tang Capital Management

Tarsus Pharmaceuticals (TARS)
Galapagos Nv Spon Adr (GLPG)
Aurinia Pharmaceuticals (AUPH)
Ptc Therapeutics I (PTCT)
Mirum Pharmaceuticals (MIRM)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Immunocore Hldgs Ads (IMCR)
Kalvista Pharmaceuticals (KALV)
Miragen Therapeutics (VRDN)
Compass Therapeutics (CMPX)
Celcuity (CELC)
Merus N V (MRUS)
Spyre Therapeutics Com New (SYRE)
Relay Therapeutics (RLAY)
Lenz Therapeutics (LENZ)

View all positions for Tang Capital Management

Top funds holding Athira Pharma

Perceptive Advisors
BML Capital Management
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
Renaissance Technologies
Acadian Asset Management
Pathstone Holdings
BlackRock
Citadel Advisors
Geode Capital Management
Susquehanna International
Two Sigma Advisers
State Street Corporation

View all funds holding Athira Pharma